One year of qualification
Audited Supplier
In This Store
![3-(2-Chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one](https://eimg.pharmasources.com/image/20230321/FWPlNy0RxhfzyNIlRm5gToaFbRvNh7bT41Hnca4c.jpeg!200)
Jinan Finer Chemical Co., Ltd is professional to manufacture and R&D chemical intermediates, pharmaceutical intermediates and fine chemicals. Company locates in Jinan city new material industry park which is approved by Shandong province government, so the company has great advantages in enterprise credit, finance security, product quality control and cargo export.
The pharmaceutical intermediates are mainly applied to anti-cancer, anti-depression, cardiovascular, diabetes and other new medicine. The chemical intermediates mainly refer to heterocyclics and OLED intermediates.The company built new factory to produce new fine chemical materials which are mainly used in water treatment, bactericidal and anti-corrosion, dyes, electronic materials and other industry fields.
Finerchem has export & import license, and hazard chemical sales license. The products are exported to America, Brazil, South Korea, Japan, Taiwan, Malaysia, Thailand, Indonesia, Europe union and other countries or regions.
Under rich experiences and excellent international reputation, the company becomes a quite influential enterprise in China's chemical field. FinerChem sincerely look forward to establishing long good cooperation with our customers from all over the world.
Year of Establishment: 2015
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 50-100
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages:
Patents and Copyrights:
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us：
Pharma Sources Insight JANUARY 2024
![4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile](https://eimg.pharmasources.com/image/20230321/YIqg5K8UsFJDlu4y7h9CKTyQhtc6fzwbla0ByOnM.jpeg!200)
![4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile hydrobromide](https://eimg.pharmasources.com/image/20230317/AhgZgxjunkhQeKiSQKZDFJvUsKbn07PVyKk50KmP.jpeg!200)
![4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester](https://eimg.pharmasources.com/image/20230317/3lCqeuyv89yotcACGjsojcit5sbn1o4meXkWVXlR.jpeg!200)
